The Surveillance and Evaluation Unit of the Center for Cancer
Prevention and Control has been created as a result of the tobacco
settlement under the Cancer Prevention, Education, Screening and
Treatment Program of the Cigarette Restitution Fund (CRF) Program. The
purpose of the Surveillance and Evaluation Unit is to:
The report contains information
on cancer incidence, mortality, stage
of disease at diagnosis, public health evidence for prevention and screening,
recommended areas for public health intervention, and Maryland screening
behaviors compared to Healthy People 2020 and the Maryland Comprehensive Cancer
Control Plan targets for cancer prevention and screening.
Statewide Maryland Cancer Surveys (MCS) were conducted in
2002, 2004, 2006, and 2008 and related reports were developed during that time.
The MCS was commissioned by the SEU and performed by the Department of
Epidemiology and Preventive Medicine at the University of Maryland, Baltimore,
School of Medicine. The purpose of the survey was to determine cancer screening
rates and measure cancer risk behaviors among persons age 40 years and older, living
in Maryland, for selected cancers. Since the last MCS was conducted, the
Maryland Behavioral Risk Factor Surveillance Survey has been conducted on a
yearly basis. The survey focus includes: risk behaviors, cancer screening,
and other related behaviors among adults age 18 years and older and other
subgroups such as the Hispanic/Latino population in Montgomery County and
adults age 18 and older in Baltimore City.
Data is obtained from various sources to identify trends in
cancer screening and costs associated with hospitalizations. Data sources
include the Maryland Cancer Registry,
Behavioral Risk Factor Surveillance Study, Vital Statistics, Maryland Health
Care Commission, as well as hospital discharge data, endoscopy units, and
selected cancer screening among Health Maintenance Organizations in Maryland.
The Surveillance Advisory Committee was established to assist
the SEU with epidemiological output issues and provide guidance on surveillance
and evaluation issues. The Committee meets on an ad-hoc basis. Visit Cancer Surveillance Information Resources for more
information regarding Cancer-related Surveillance activities.
The CDB was created in 2004, and is intended to capture
information about screening, diagnosis, and treatment of targeted cancers, and
patient navigation, among eligible persons as determined by each local
CRF-CPEST program. The CDB is a confidential database is available for local
programs via the DHMH Intranet.
The EDB was created to capture non-confidential information
relating to cancer outreach, education, and publications as performed and developed
by local CRF-CPEST programs. EDB data is used as a comprehensive tracking tool
for program outreach and education efforts. The EDB is Internet-based so that
local program staff can enter data, analyze data, and run reports.
The SEU performs quality assurance reviews of CDB and EDB data.
These reviews involve a comprehensive review of data for accuracy, consistency,
case management, and adherence to Minimal Elements for cancer screening,
diagnosis, treatment, follow-up and education. Quality Assurance reviews are
conducted prior to and during site visits to local CRF-CPEST programs.
The SEU responds to technical inquiries relating to
the CDB and EDB and handle requests for surveillance and evaluation information
For additional information about Cancer for Cancer Surveillance and
Control, Surveillance and Evaluation Unit, call 410-767-0791.
201 W. Preston Street, Baltimore, MD 21201-2399
(410) 767-6500 or 1-877-463-3464